title: [Administration of Neovasculgen agent for treatment of a patient with neuroischaemic form of diabetic foot syndrome].
abstract: Presented herein is a case report concerning successful treatment of a patient with the neuroischaemic form of diabetic foot syndrome using Neovasculgen(®) agent. This case by salvage of the supporting leg could have been considered unpromising without the use of the methods of therapeutic angiogenesis. The use of Neovasculgen(®) made it possible to obtain an optimal result with rehabilitation of the patient and preserving the initial level of his quality of life.
authors.affiliation: Chair of General Surgery, Uralian State Medical University, Ekaterinburg, Russia.
authors.forename: E P
authors.initials: EP
authors.lastname: Burleva
authors.affiliation: Sverdlovsk Regional Clinical Hospital No1, Ekaterinburg, Russia.
authors.forename: Yu V
authors.initials: YV
authors.lastname: Babushkina
mesh_terms: D000671:Amputation, Surgical / Q000009:adverse effects / Q000379:methods; D043925:Angiogenesis Inducing Agents / Q000008:administration & dosage*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis; D017719:Diabetic Foot / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D003929:Diabetic Neuropathies / Q000503:physiopathology*; D004333:Drug Administration Routes; D006801:Humans; D008297:Male; D008875:Middle Aged; D013530:Surgical Wound Infection / Q000188:drug therapy*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
chemical_list: D043925:Angiogenesis Inducing Agents